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Identification  of antibody  populations  that  share  variable  region  determinants 
(idiotypes) among all individuals of an inbred strain has greatly facilitated the study 
of mechanisms  that  govern  specific  immune  responses.  In  almost  all  cases,  such 
idiotypes constitute a major portion of the antibody response, although the degree of 
clonal dominance may vary with the number of immunizations or during the course 
of a response. The observations that (a) idiotype expression can be genetically mapped 
to the heavy chain variable region (VH) 1 (1), (b) DNA sequences for these specificities 
can be isolated from a sperm genomic library (2), and (c) restriction enzyme patterns 
of VH correlate with  idiotype and  allotype inheritance  (3)  suggest  that  at least one 
mechanism of clonal dominance is due to the fact that these clonotypes are the direct 
expression of germ line genetic information.  It is likely that  additional  mechanisms 
are involved in this process for several reasons.  First, many inherited  idiotypes have 
been found to comprise large families of closely related specificities (4-9), and there 
can  be significantly greater degree of heterogeneity in  idiotype-bearing hybridoma 
proteins characterized than is indicated by analysis of serum idiotype (4, 5).  Second, 
the expression of an  idiotype that  recurs  among all  individuals  of an  inbred  strain 
(cross-reactive idiotype;  CRI)  may represent  the  dominant  specificity in  one strain 
but constitute a minor clonotype in another (10,  11). Third, genetic information other 
than  that  coding  for immunoglobulin  structural  genes can  influence  the expressed 
heterogeneity  of some  antibody  responses  (11,  12)  and  can  affect  the  ontogeny  of 
clonotype development (13). 
Such observations suggest that there might be a discrepancy between the clonotype 
diversity present at the precursor cell level (potential repertoire) and what is eventually 
expressed at the level of the serum antibody response (expressed repertoire).  One of 
the  clearest  examples of this  phenomenon  is  in  the  response  to  phosphorylcholine 
(PC). The murine serum response to PC is composed almost exclusively of antibodies 
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corresponding to the myeloma proteins M511, M603, and T15 (14). However, there 
is considerably more heterogeneity in the IgM precursor cell repertoire analyzed at 
limiting dilution in the splenic focus system  (15)  or with monoclonal anti-idiotypic 
reagents (16,  17). In addition, whereas C57BL/6 mice express only one of two allelic 
forms of T 15 in their serum anti-PC antibody (corresponding to the myeloma protein 
CBPC3), the other allelic form can be found at the precursor cell level in these mice 
(18).  Indeed, certain BALB/c ×  C57BL/6 recombinant-inbred strains may have as 
high  a  representation of the  nonexpressed allele as  strains  that  express it,  such  as 
BALB/c. 
We have chosen  to examine the  B  cell repertoire specific for azophenylarsonate 
(ARS)  as a  model in which to study the regulation of repertoire expression. A large 
proportion (20-70%) of ARS-specific antibodies from A/J mice share a cross-reactive 
idiotype (CRIA) that comprises a family of closely related but nonidentical clonotypes, 
as shown by amino acid sequence analysis of CRIA-positive hybridoma proteins (4- 
6). Anti-idiotypic sera raised against an ARS-specific hybridoma protein unrelated to 
the major CRIA can identify a "minor" idiotype population, constituting 5-10% of all 
anti-ARS  antibody in  individual A/J  mice  (10,  19,  20).  In  all  BALB/c mice, this 
same minor idiotype represents the predominant clonotype family (CRIc) expressed 
in the anti-ARS response (10). Individual mice can also produce anti-ARS antibodies 
with idiotypes that are unique to the individual, and these idiotypes may be in low to 
undetectable  concentrations  in  other  immunized  mice  of the  same  strain  (6,  21). 
Therefore, the serum anti-ARS response appears to be extremely heterogeneous, but 
certain  strains  express  characteristic  levels  of major  and  minor  idiotype  families, 
making this an excellent choice for analysis of repertoire expression. 
In this report, we examine the expression of the predominant CRIA in the ARS- 
specific B cell repertoire of A/J and BALB/c mice. Surprisingly, only 2.6% (7 out of 
267) of primary A/J ARS-specific monoclonal antibodies generated in the limiting 
dilution splenic focus system possess  the predominant  CRIA,  and  2 of 10 BALB/c 
mice also  had  CRIA-positive precursor cells  in  their nonimmune  repertoire. When 
A/J mice are immunized with ARS-protein conjugates, the serum antibody response 
and  precursor  cell  population  are  dominated  by  CRIA.  The  frequency of CRIA- 
positive B cells increases over  100-fold after immunization, whereas CRIA-negative 
precursor  cells  may  initially  decrease,  followed by  a  later  rise  in  frequency.  The 
observation that the CRIA family can be identified in both BALB/c and A/J mice, 
along with the striking discrepancy in the expression of this  idiotype family at the 
serum and precursor cell levels, implies the existence of complex regulatory networks 
that both augment the expression of certain idiotypes and suppress the appearance of 
others. 
Materials and Methods 
Antigens.  Limulus  polyphemus hemocyanin  (Hy), ovalbumin  (OA),  and  bovine serum 
albumin (BSA) were purchased from Sigma Chemical Co., St. Louis, MO. ARS20-OA, ARSIs- 
BSA, and 3-(p-arsonophenylazo)-N-acetyl-L-tyrosyl-glcylglycine Boc hydrazide-Hy (ARS-TGG- 
Hy, 10 mol ARS-TGG per 100,000 mol wt Hy) were prepared as described elsewhere (22, 23), 
and the coupling ratios were determined by methods described for other protein antigens  (23). 
Animals and Immunizations.  6-wk-old male BALB/e ByJ and A/J mice were obtained from 
The Jackson Laboratory, Bar Harbor, ME. Neonatal mice were bred in our mouse colony from 
mice obtained from The Jackson Laboratory. Mice to be used as Hy-primed recipients received 1354  FREQUENCY  OF CROSS-REACTIVE  IDIOTYPE-POSITIVE B CELLS 
0.1  mg Hy intraperitoneally in complete Freund's adjuvant  (CFA) 8-12 wk before use. A/J 
mice were immunized with 0.2 mg ARS-OA in CFA followed 4 wk later by 0.2 mg ARS-OA 
in incomplete Freund's adjuvant. 
Cell Transfers and Fragment Cultures.  Monoclonal antibody responses were obtained in vitro 
using the splenic fragment culture assay system, as described by Klinman (24).  In brief, donor 
cells were transferred intravenously into syngeneic Hy-primed recipients that had been irradi- 
ated with  1,300 rad 4 h  previously. Fragment cultures were prepared  16 h  after cell transfer 
and  stimulated  with  ARS-TGG-Hy  (1  x  10 .6  M  hapten)  in  Dulbecco's  modified  Eagles 
medium (Ontario Cancer Institute, Toronto, Ontario), 10% fetal calf serum (Gibco Laborato- 
ries,  Grand  Island  Biological  Co.,  Grand  Island,  NY),  2  mM  glutamine,  and  50  ~g/ml 
gentamicin (Schering Corp., Kenilworth, N  J). Culture fluids were changed every 3 d, and fluids 
collected 9-13 d after stimulation were assayed for anti-hapten antibodies. 
Radioimmunoassay.  Detection of antibody in culture supernatants was accomplished using a 
solid-phase radioimmunoassay, as described previously (25).  Rabbit anti-mouse F(ab')2 anti- 
body was purchased from N. L. Cappel Laboratories, West Chester, PA., purified by absorption 
and elution from a  mouse IgG +  IgM-Sepharose 4B column, and labeled with 125I. Idiotype 
assays were performed in  a  competitive radioimmunoassay, as previously described (26).  In 
brief, 0.1 ml of the appropriate dilution of rabbit anti-CRI, kindly provided by Dr. A. Nisonoff, 
Brandeis University, Waltham, MA, in 0.05 M Tris, pH 9.0, was adsorbed to wells of polyvinyl 
plates (Dynatech Laboratories, Alexandria, VA). This reagent has been well characterized in 
Dr.  Nisonoff's laboratory (6).  After phosphate-buffered saline, pH  7.2  (PBS), containing  1% 
BSA was added for  1 h  and removed, 20 kd of culture supernatant  or a  serum dilution was 
added, followed by 2 ng of 125I-labeled  hybridoma protein R16.7  or purified A/J anti-ARS 
antibody, provided by Dr. Nisonoff. After incubation at 37°C for 18 h, the wells were washed 
with  PBS  and  counted  in a  gamma counter.  Anti-hapten and  idiotype radioimmunoassays 
were run in parallel on culture supernatants and serum samples, using R16.7 as the standard 
in  both  assays.  Monoclonal antibodies reacting on  a  1:1  weight  basis in  the anti-ARS and 
idiotype assays were designated CRIA positive, partial reactivity was  defined as anti-ARS/ 
idiotype ratio from 2:1 to 10:1, and CRIa-negative clones had a ratio greater than  10:1. 
Results 
Frequency of ARS-spec~'c  Precursor Cells in A/J Adult Mice.  The data in Table I  lists 
the frequency of ARS-specific precursor cells in 13 nonimmune A/J mice. The average 
frequency  for  the  group  was  1/68,000  splenic  B  cells, with  all  donors  falling  in  a 
relatively narrow  range  of 6.3  to  30  per  10 ~ B  cells.  Supernatants  from  fragment 
cultures  containing  anti-ARS antibodies were  subsequently  assayed  for  CRIA  in  a 
competitive  radioimmunoassay.  This  assay  used  a  rabbit  anti-CRI  raised  against 
purified A/J anti-ARS antibody and a  CRIA-positive hybridoma R16.7.  The results 
in Table I show that only 7 of the 267 ARS-specific monoclonal antibodies analyzed 
were  reactive on  a  1:1  weight  basis in  this  idiotype assay (CRIA+);  another  15  foci 
could be designated as CRIa-cross-reactive (CRIA+). Thus,  the average frequency of 
CRIA-positive B  cells in this group of nonimmune A/J mice is  1 in 2.8  ×  l0  s splenic 
B  cells. Each donor had, at most, one focus positive for CRIA, whereas there were no 
CRIA+ clones in approximately one-half the individuals. This distribution is consistent 
with the random distribution of a  rarely occurring clonotype. 
The surprisingly low frequency of CRIA+  precursor cells is in marked contrast  to 
its dominant expression in the serum  antibody (6)  and primary plaque-forming cell 
responses  (27).  We questioned whether  this finding accurately reflects the represen- 
tation of this idiotype family in the nonimmune  B  cell pool. First, it is possible that 
the competitive radioimmunoassay used may not identify some molecules traditionally 
considered to be CRIA+ in other idiotype assays. To test this, we compared the ability 
of a  group of ARS-specific monoclonal antibodies to inhibit the interaction between NOLAN  H.  SIGAL 
TABLE  I 
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Donor* 
Total number  Precursor fre- 
cells transferred  Positive  quency (per 106 
(× lOe)  foci  B cells):~ 
Percent of clones 
with CRIA 
reactivity§ 
+  ±  - 
1  74  10  8.8  10  10  80 
2  87  11  8.1  0  9  91 
3  144  20  8.8  5  5  90 
4  93  37  24.4  3  21  75 
5  126  26  12.5  0  0  100 
6  135  32  14.3  3  3  94 
7  100  10  6.3  0  0  100 
8  142  27  11.9  4  0  96 
9  42  19  28.1  0  0  100 
10  60  29  30.0  7  0  93 
11  80  27  21.3  0  7  93 
12  64  8  8.1  12  0  88 
13  79  11  8.8  0  9  91 
Totals/average  1,226  267  14.7  ±  8.1  3  6  91 
* Spleen cells  (15-20 ×  106) from each donor were transferred into 4-8 Hy-primed 
recipients. 
:~ Calculation based on a cloning efficiency of 4% for the splenic focus assay and the 
percentage of B cells in the spleen (25). 
§ Monoclonal antibodies reacting on a  1  : 1 weight basis in the anti-ARS and idiotype 
assays were designated CRIA positive(+); partial reactivity was defined as an anti- 
ARS/idiotype ratio of from 2:1 to 10:1; CRIA-negative clones (CRIA-) had ratios 
greater than 10:1. 
TABLE  II 
Correlation between CRIA Assays Using Hybridoma Protein RI 6. 7 or Purified 
Anti-ARS Antibodies as Labeled Ligand 
Number of clones 
with CRIA reactiv- 
ity using anti-ARS 
Number of clones with CRIA reactivity using R 16.7 
+  -F  -- 
+  2  2  0 
±  1  10  6 
-  0  0  52 
rabbit anti-CRI  and labeled serum anti-ARS  antibody. This assay may detect broader 
idiotypic  determinants  than  identified by the use of R16.7  as  the labeled  ligand.  73 
monoclonal  antibodies  derived  from A/J  nonimmune  spleen fragment  cultures were 
assayed  in parallel  for both  idiotypic specificities. Table  II lists the number  of clones 
falling into each reactivity pattern  and reveals generally good correlation between  the 
two  assays.  Approximately  10%  (6 out of 58)  of the antibodies  designated  as CRIA- 
were  found  to  be cross-reactive  in  the assay  using serum  anti-ARS  as  ligand.  All  of 
these  antibodies  had  anti-ARS/idiotype  ratios  close  to  10:1  and  never  gave  >20% 
inhibition  in  the  radioimmunoassay.  Therefore,  both  assays  appear  to  identify  the 
major  CRIA  public  specificity  and  yield  equivalent  results  in  the  analysis  of these 
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Effect  of  Immunization  on  Precursor Frequency and  Representation  of  CRIa  in  A/J 
Mice.  Another possible explanation for the low representation of the CRIA family in 
the nonimmune  B  cell pool  is that  the spleen  fragment  culture conditions may not 
efficiently stimulate  the  population  containing CRIA+  precursor  cells,  perhaps  be- 
cause  of the  form  of antigen  used  or because  of the  absence  of an  idiotype-specific 
helper T  cell (28).  These questions can be addressed  by examining the ARS-specific 
B  cell repertoire of A/J  mice immunized with an  ARS-protein conjugate.  It can  be 
predicted that the dominant expression of CRIA in the anti-ARS serum response after 
immunization should  be  paralleled  by  a  rise  in  the  frequency of CRIA+  B  cells in 
splenic fragment cultures. Thus, only the source of donor cells would change from the 
study of the nonimmune repertoire. In addition, these studies can determine the effect 
of immunization on both the CRIA+ and CRIA-  precursor cell populations. 
10 A/J mice were immunized with 0.2  mg ARS-OA in  CFA, and 6  of these mice 
were boosted  1 mo later with the same antigen in incomplete Freund's adjuvant.  At 
various  times  after  primary  or  secondary  immunization,  the  mice were  bled,  their 
spleen  cells  transferred  into  Hy-primed  recipients,  and  fragment  cultures  prepared 
and stimulated with ARS-TGG-Hy. As shown in Table III, A/J mice produced low 
levels  of  anti-ARS  on  primary  immunization,  which  increased  considerably  on 
reimmunization. The proportion of CRIA contained in the immune sera ranged from 
30-100%;  detectable  levels of CRIA were  never  demonstrated  in  nonimmune  A/J 
serum.  The  effect  of immunization  on  precursor  frequency  and  representation  of 
CRIA is listed in Table III and depicted graphically in Fig.  1. The data demonstrate 
that,  early after immunization, there is a  decrease in splenic precursor  frequency to 
undetectable  levels  (donors  1  and  2)  followed by  a  rise  in  the  frequency  of ARS- 
specific  precursor  cells.  The  majority  of  these  B  cells  produce  antibody  that  is 
TABLE  III 
Effect of Immunization on Precursor Frequency and Representation of CRIA in A/J Mice 
Serum  Number of  Time after  Total number  Positive  Donor  immuniza-  immuniza-  cells trans- 
tions*  tion  ferred (x  10  6)  loci 
Percent  Anti-ARS  CRIA 
Percent of 
clones with 
CRIA 
reactivit  y:~ 
+  +_  - 
~g/ml 
1  1  10  21  40  34  0 
2  l  10  6  17  36  0 
3  1  24  22  47  36  3  33 
4  1  24  18  102  39  15  73 
5  2  20  135  114  46  47  68 
6  2  20  150  43  38  57  79 
7  2  34  2,400  30  27  20  70 
8  2  34  1,160  43  27  18  94 
9/10  2  60  930  31  84  72  22 
33  33 
0  27 
17  15 
10  11 
15  15 
0  6 
22  55 
* 10 A/J adult  mice were immunized with 0.2 mg ARS-OA in complete Freund's adjuvant,  followed, in 
some cases, with another  immunization  30 d later in incomplete Freund's adjuvant.  At the indicated 
times after primary or secondary immunization, mice were bled, their spleens removed, and  2 8 x  106 
cells transferred into synergic recipients for assay in the splenic focus system. 
Positive foci were assayed for the presence of CRIA, as described in Table I. 100- 
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Fie.  1.  Effect  of immunization  on ARS-specific precursor frequency and representation  of CRIA 
in A/J mice at various times after immunization.  10 A/J mice were immunized with 0.2 mg ARS- 
OA in CFA, followed by another immunization  30 d later in incomplete Freund's adjuvant. At the 
indicated times after immunization,  spleen cells from  the mice were transferred  into  syngeneic 
recipients for analysis in the splenic focus assay. Positive foci were assayed for the presence of CRIA. 
The  figure plots  this  data as precursor  frequency  (per  10  n cells) vs.  time after immunization. 
CRIA+ clones (m), CRIA+ clones (l~), and CRIA- clones (I-'1). 
idiotypically identical to or cross-reactive with the CRIA. During the peak expansion, 
the CRIA+ precursor pool increases, on the average, over 100-fold, from  1/2.8  ×  106 
B  cells  in  nonimmune  mice  to  1/17,500  B  cells  in  donors  5  and  6.  The  CRIA  + 
population undergoes a  less dramatic increase in frequency, and the representation of 
this group is somewhat more variable from individual to individual. 
The frequency of precursor B cells that produe CRIA- antibodies initially decreases 
after immunization with ARS-OA and remains lower than preimmune levels for most 
of the  time-course examined.  Only at  very late times  after  immunization  does  the 
CRIA-  population  increase  significantly  (donors  9/10).  Thus,  the  three  idiotype 
families that  can  be defined at  this level demonstrate  independent  kinetics after in 
vivo immunization. In addition, this experiment confirms the prediction that immu- 
nization leads to an almost exclusive increase in the CRIA+ precursor cell population. 
Ontogeny of ARS-specific Precursor Cells and CRIA in A/J Mice.  We  next  wanted  to 
follow the acquisition of ARS-specific precursor cells during ontogeny and, in partic- 
ular,  determine  when  during  development  the  CRIA+  precursor  cells  arise.  This 
experiment addresses whether the predominance of CRIA in the adult A/J anti-ARS 
response is accounted for by its early appearance during the development of the B cell 
repertoire. Because the germ line VH genes that code for CRIA have been cloned and 
sequenced  (29),  the ontogeny of these specificities may also provide information on 
the  early  events  that  shape  antibody  diversity.  The  results  shown  in  Table  IV 
demonstrate that ARS-specific B cells are present in relatively high frequency at birth 
and in the early neonatal period, but  there are no CRIA+ clones in this population. 1358  FREQUENCY  OF  CROSS-REACTIVE  IDIOTYPE-POSITIVE B  CELLS 
Age 
TABLE  IV 
Ontogeny of ARS-spec~'c  Precursors and CRIA in A/J Mice 
Percent of 
Total hum-  Precursor  clones with  Number  Posi- 
her of cells  frequency  CRIA 
of neo-  tive 
transferred  (per  10  6 in-  reactivity§ 
nates*  foci  (X  106)  jected cells):l: 
+  _____  - 
days 
0  4  13.6  31  57.5  0  0  100 
0  7  18.2  11  15.  0  0  100 
1  6  15.4  8  12.8  0  0  100 
3  8  30.4  47  37.5  0  0  100 
3  4  15.2  18  30.  0  0  100 
3  5  18.0  20  27.5  0  0  100 
6  12  154  27  4.5  0  11  89 
6  6  108  53  12.3  0  4  96 
* Spleen  cells  from individual  neonates were transferred into  1-4 syngeneic 
recipients and assayed for the presence of ARS-specific precursor cells in the 
splenic focus system. 
:~ Calculation based on a cloning efficiency  of 4% (25). 
§ Positive foci were assayed for the presence of CRIA, as described in Table I. 
TABLE  V 
Frequency of ARS-spec~'c  Precursor Cells in BALB/c Mice 
Donor* 
Total number  Precursor fre- 
cells trans-  Positive  quency (per 10  ~ 
ferred (X  10  ~)  foci  B cells):]: 
Percent of clones 
with CRIA 
reactivity§ 
+  +  - 
1  120  18  9.4  28  6  66 
2  50  8  10.0  0  13  87 
3  48  3  3.9  0  0  100 
4  144  9  3.9  0  22  78 
5  100  11  6.9  0  0  100 
6  90  5  3.5  0  0  100 
7  64  9  8.8  0  0  I00 
8  72  9  7.8  0  11  88 
9  92  6  4.1  17  0  83 
10  115  12  6.5  0  0  100 
Totals/averages  895  90  6.5  +  2.5  7  6  87 
* Spleen cells  (15-20  X  106) from each donor were transferred into 4-8  Hy-prinned 
recipients. 
Calculation based on a cloning efficiency  of 4% for the splenic focus assay and the 
percentage of B cells in the spleen (25). 
§ Positive foci were assayed for the presence of CRIA, as described in Table I. 
CRIA±  clones begin to arise at ~  1 wk of age. The  ontogeny  of ARS-specific  precursor 
cells follows a  similar pattern  in BALB/c  neonates  (23), and  there is complete  absence 
of CRIA+  and  CRIA +  clonotypes  in the early neonatal  period  (data  not  shown). 
It  is  interesting  to  note  that  the  frequency  of ARS-specific  precursor  cells  in  the NOLAN  H.  SIGAL  1359 
spleen falls during the 1st wk of life. This same phenomenon was observed previously 
in the development of the BALB/c ARS-specific repertoire, where there is a  20-fold 
decrease in relative frequency during the  1st wk of life (23).  In the previous study, it 
was shown that the apparent decrease in frequency is due to the fact that  the total 
number  of ARS-specific  B  cells  per  spleen  remains  constant  during  the  newborn 
period, at the same time that the number of B cells responsive to other antigens, and 
splenic B cells in general, is increasing logarithmically. 
Frequency of  ARS-specific Precursor Cells in BALB/c Mice.  BALB/c mice do not express 
CRIA  in  their anti-ARS  immune  response.  However, as  shown  in  the  PC-specific 
repertoires  of some  inbred  strains  (15-18),  there  can  be  a  dramatic  discrepancy 
between what is present at the clonal precursor cell level and what is expressed in the 
serum antibody response. Therefore, we wanted to determine whether BALB/c mice 
have the potential to express CRIA in their nonimmune repertoire, even though they 
never use this specificity in the production of anti-ARS antibody. Table V  lists the 
frequency of ARS-specific precursor cells in BALB/c mice and the representation of 
CRIA in 90 foci that were analyzed. 2 of 10 BALB/c mice assayed had CRIA+ clones 
in  their  nonimmune  precursor  cell  pools,  and  several  other  individuals  possessed 
CRIA+_ clonotypes among the monoclonal anti-ARS  antibodies evaluated. Overall, 
the  representation  of  these  specificities  was  no  different  than  that  observed  in 
nonimmune A/J adult mice, although the distribution of CRIA+ B cells in BALB/c 
mice  did  not  fit  the  random  distribution  seen  in  A/J  donors.  The  ARS-specific 
precursor frequency is similar to that in A/J adult mice (1  per  150,000 B cells) and 
agrees with previously published data (23). 
Discussion 
This report examines the frequency and clonal composition of the nonimmune and 
immune ARS-specific precursor cell pools in A/J and BALB/c mice. In the nonim- 
mune A/J mice assayed in the splenic focus system, only 2.6% (7 out of 267) anti-ARS 
monoclonal antibodies possess the predominant CRIA. Because ARS-specific cells are 
present  at  a  frequency of 1/68,000  B cells in the A/J mouse, the frequency of this 
entire idiotype family is  1/2.8 ×  106 splenic B cells. Upon immunization with ARS- 
protein conjugates, the representation of the idiotype increases to 20-80% of the ARS- 
specific repertoire, and the secondary precursor cell pool now accurately reflects the 
idiotype  composition  of the  serum  antibody  response.  Thus,  there  is  a  striking 
distinction between the representation of this clonotype family at the precursor cell 
level in the primary and secondary repertoires. In addition, BALB/c mice have the 
potential to generate CRIn-positive precursor ceils within their nonimmune repertoire 
because two of the BALB/c mice analyzed produced CRIA+ monoclonal antibodies 
in splenic fragment cultures. The data provide evidence to suggest that a complex set 
of regulatory phenomena influence precursor cell and serum antibody expression. 
Both the low frequency of CRIA+ precursor cells in nonimmune A/J mice and the 
identification of CRIA+ B cells in BALB/c mice were unexpected observations that 
rely on the sensitivity and specificity of the idiotype assay used. The rabbit anti-CRI 
used  in  this study was  generously provided by Dr.  A.  Nisonoff and  has been well 
characterized in his laboratory (6).  The inhibition radioimmunoassay requires that 
anti-ARS  antibody  displace  the  strongly  CRIA+  hybridoma  protein  R16.7  from 
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some molecules traditionally considered to be members of the CRIA family in other 
assays, those culture supernatants observed to inhibit this interaction as well as R16.7, 
which  include  the  BALB/c  clonotypes,  must  be considered  CRIA+.  Table  II also 
shows that  there  is  good correlation  in  the  identifcation  of CRIA antibodies  when 
either R16.7  or purified A/J anti-ARS antibody is used as the labeled ligand in the 
idiotype assay. Furthermore, the identification  of up to 94% CRIA+ precursors cells 
from immunized A/J mice and detection of the expected proportion of CRIA in the 
serum of these mice suggest that we are not missing a significant proportion of CRIA+ 
monoclonal antibodies in the analysis of the primary repertoire. 
The notion that the primary anti-ARS response is heterogeneous has been implied 
in a number of previous studies and is supported by the data presented in this report. 
Amino acid sequence analysis of CRIA+ and CRIA- hybridoma proteins have shown 
that variations occur both in framework and hypervariable regions  (4-6).  Although 
there appears to be 90% homology between the heavy or light chains of any pair of 
CRIA+ hybridoma proteins,  identical  sequences are rare, and the entire family has 
been estimated to consist of at least  100  different  sequences  (21).  At the serological 
level, heterogeneity can be demonstrated  by the variation in  inhibitory capacity of 
hybridoma proteins in CRI assays and by the presence of private idiotypic determi- 
nants  on  individual  hybridoma proteins  (6,  21).  Suppression of neonatal  A/J  mice 
with  anti-idiotypic sera followed by immunization  with  an ARS-protein  conjugate 
causes complete suppression of that idiotype, with little effect on the total anti-ARS 
response, and these hyperimmune suppressed mice produce anti-ARS antibodies that 
also possess private idiotypic determinants  (30,  31).  In light of the diversity revealed 
in the expressed ARS-specific repertoire,  it  is perhaps not  surprising to observe the 
extensive  heterogeneity  at  the  precursor  cell  level  in  limiting  B  cell  cultures  of 
nonimmune mice. 
Although the expressed repertoire may be very heterogeneous, it would appear that 
individual A/J mice use only a fraction of their available ARS-specific precursor cells. 
Conger et al.  (27)  recently examined the kinetics of the primary plaque-forming cell 
response in A/J mice after in vivo immunization with 500/zg ARS-Hy. They found 
that  -80% of the IgM plaque-forming cells and close to  100% of the IgG cells were 
CRIA+  within  the  first  1-2  wk  after  immunization.  The  kinetic  analysis  strongly 
indicated that CRIA+ IgM plaque-forming cells were preferentially switched to IgG 
in the primary response, and the authors postulate that CRIA+ B cells receive more 
T  cell  help  than  CRIA-  ones.  Because  CRIA+  precursor  cells  represent,  on  the 
average, only 2.6%  of ARS-specific B  cells,  or  -100  CRIA+  B  cells per mouse, the 
findings  suggest an  almost exclusive expansion of this clonotype family on contact 
with antigen. Using the data of Conger et al. (27)  and assuming 100% recruitment of 
available precursor cells into plaque-forming cells, CRIA+ B cells must expand with 
a  doubling  time of 20 h;  the later appearance of CRIA- IgM plaque-forming cells 
might  represent  a  slower expansion  of the CRIA-  precursor  cell  pool or the  rapid 
emergence of variants from the  CRIA+ population.  Indeed,  the CRIA- clonotypes 
that are eventually expressed in the primary and secondary responses might represent 
the expansion of only a small portion of the nonimmune repertoire, perhaps as small 
as the CRIA+ family. 
At early times after immunization, when the plaque-forming cell response is at its 
peak, cells that are detectable in the splenic focus assay have been virtually eliminated NOLAN H. SIGAL  1361 
from the spleen (Table III, donors 1 and 2). Both CRIA+ and CRIA- precursor cells 
have decreased in frequency at this time point, and when B cells begin to reappear at 
24 d after immunization, the CRIA+ B cells now dominate. The depletion of  precursor 
cells in the spleen is probably due to their differentiation into plaque-forming cells, 
which would not be "assayable" in the splenic focus system. It is important to note 
that contact with antigen affects both CRIA+ and CRIA- precursor cells in a similar 
manner.  This  observation  implies  that  both  groups  undergo  differentiation  into 
plaque-forming cells but that only CRIA+ B cells preferentially expand and produce 
the majority of long-lived memory B cells.  Although CRIA-  B cells are affected by 
contact with antigen in vivo, they do not appreciably expand before their differentia- 
tion  into  plaque-forming cells,  and  they  either  generate  few  memory cells  or  the 
process proceeds at a  much slower rate for this population. 
The question of why CRIA+  B cells preferentially expand to dominate the anti- 
ARS serum response is not specifically addressed by this study. It is clear that clonal 
dominance is not due to a  high frequency of B cells committed to the production of 
CRIA, as observed previously in an analysis T15-positive B cells within the anti-PC 
repertoire (32).  Neither is idiotypic dominance reflected in  an  early appearance of 
these  clonotypes during  B  cell  development.  Although  it  is  possible  that  CRIA+ 
precursors  may  have  a  higher  affinity  for  ARS  than  the  CRIA-  B  cells  in  the 
nonimmune repertoire, immunochemical studies on CRIA+ and CRIA-- serum anti- 
body (33)  and plaque-forming cells  (27)  would  suggest  that  affinity is not  a  major 
determining  factor.  However, those experiments analyzed the expressed repertoire, 
not the potential repertoire, so that  definitive conclusions cannot be reached about 
the affinity of CRIA-  monoclonal generated in splenic fragment cultures. The data 
presented in this report as well as experiments by other investigators (28, 34) are most 
consistent with the notion that T  cells are involved in a regulatory network to control 
the dominant expression of major idiotype populations. In particular, it would appear 
that an idiotype-specific T  helper cell preferentially expands the small CRIA+ B cell 
population in nonimmune A/J mice, resulting in secretion of antibody into the serum, 
differentiation into plaque-forming cells, and generation of memory cells. Because the 
representation  of  CRIA+  B  cells  is  no  different  than  that  of  the  nondominant 
clonotypes in  the ARS-specific repertoire, it  is presumably the presence of these T 
helper cells that is responsible for the maintenance of CRIA dominance in A/J mice. 
If T  cells do play a role in maintenance of clonal dominance, the data also suggest 
that such a mechanism may influence only rare specificities, whereas most clonotypes 
are not regulated in this  fashion, i.e., the CRIA-  precursor cells.  Perhaps  idiotype- 
specific  T  helper  Cells exist  only  with  reference  to  the  200-300  germ  line  VH 
specificities, as found in antibody responses containing predominant idiotypes, such 
as the anti-ARS,  PC,  nitrophenyl, and  dextran responses  (1).  The vast  majority of 
clonotypes in the nonimmune repertoire, many of which  may have lost their cross- 
reactive idiotypes due to somatic variation, would  remain outside of such network 
interactions. According to this model, although BALB/c mice can generate the CRIA 
specificity at the precursor cell level, perhaps as a somatic variant (see below), they do 
not normally express this clonotype in their serum anti-ARS  response because they 
lack the appropriate T  helper cell. This mouse strain does predominantly express the 
CRIc family because it possesses  the corresponding helper cell, and it would follow 
that  CRIc is encoded by a  germ  line VH gene in  BALB/c mice. Thus, the genetic 1362  FREQUENCY  OF CROSS-REACTIVE IDIOTYPE-POSITIVE B CELLS 
linkage of idiotype expression to VH might not be due to the presence or absence of 
an immunoglobulin structural gene per se (because all strains might have the ability 
to carry the clonotype in their nonimmune B cell repertoire), nor would it be due to 
the ability to maintain a high frequency of the predominant idiotype in the precursor 
cell  pool.  Instead,  predominant  idiotype expression  may require  the  presence of T 
cells that use or recognize the products of germ line VH structural genes. 
Support  for the hypothesis discussed  in  the preceding paragraphs comes, in part, 
from the  finding  of CRIA+  precursor  cells  in  the  BALB/c  nonimmune  repertoire. 
This observation mirrors previous experiments in the splenic fragment system, where 
it was  found  that  C57BL/6  mice can  have a  significant  representation  of the  TI5 
"framework" idiotype at  the precursor cell level but  do not express this  idiotype in 
their  serum  anti-PC  response  (18).  Lucas  and  Henry  (35)  also  recently  identified 
CRIA+ plaque-forming cells in BALB/c mice after in vivo immunization with the T- 
independent  antigen  ARS-Brucella  abortus.  It  is  highly  unlikely  that  monoclonal 
antibodies  identified  as  CRIA+  in  BALB/c  splenic  fragment  culture  supernatants 
actually belong to the CRIc idiotype family. The anti-CRIA serum used in this study 
is only weakly cross-reactive with CRIc, although some of the antibodies identified as 
CRIA+ may be members of the CRIc family. 
Although CRIA+ precursor cells were found in approximately one-half the individ- 
ual  A/J  mice  analyzed  and  were  distributed  in  a  random  fashion,  the 
BALB/c  CRIA+  clonotypes were clustered  in  two  individuals.  Because  a  VH  gene 
coding  for CRIA molecules has  not  been  found  in  the  germ line  DNA of BALB/c 
mice  (M.  Gefter,  personal  communication),  this  specificity  must  have  arisen  via 
somatic  diversification  in  those  individuals.  Given  the  probability  of the  somatic 
events that might be required for the generation of such CRIA+ B cells, this clonotype 
might  recur  relatively rarely in  the  BALB/c  strain  as  a  whole.  Indeed,  Lucas  and 
Henry (35)  identified CRIA+ plaque-forming cells in 3 of 17 BALB/c mice, which is 
similar  to  our  detection  of CRIA+  precursor  cells  in  2  of  10  individuals.  Thus, 
although not all BALB/c mice may possess this idiotype family, because it must arise 
as a  somatic variant in  this strain,  the critical point  remains that  these  individuals 
who have generated CRIA+ B cells do not express this specificity in their serum anti- 
ARS  response  when  challenged  with  a  T-dependent  antigen  (6,  10  and  N.  Sigal, 
unpublished  results).  The observation that  the CRIA specificity can be found in the 
nonimmune  BALB/c  repertoire  is  similar  to  the  identification  of  an  M167-1ike 
clonotype, also a known somatic variant, among PC-specific IgM-producing precursor 
B  cells  (15).  Thus,  these  data  support  the  contention  that  antibody  diversification 
occurs early in B cell differentiation. 
The  ontogeny  of ARS-specific  B  cells  in  A/J  and  BALB/c  mice  follow  similar 
kinetics,  with relatively high precursor frequencies in  the newborn period,  followed 
by a decline in the overall frequency of ARS-specific cells during the first week of life 
(23).  This  decline  in  frequency  has  been  shown  to  reflect  the  fact  that  the  total 
number of ARS-specific B cells per spleen remains constant during this period, at the 
same time that  the number of splenic  B  cells is  increasing.  The late appearance of 
CRIA+ B cells in the A/J spleen parallels the ontogeny of the T15 clonotype in the 
BALB/c  neonate  (26).  Whereas  the  earliest  arising  PC-specific clonotypes  are T15 
positive, a large number of ARS-specific precursor cells develop before the appearance 
of CRIA+  B  cells  in  the  A/J  mouse.  We  have  not  ruled  out  the  possibility  that NOLAN H.  SIGAL  1363 
CRIA+  B cells may first develop in the fetal or neonatal liver and  never reach the 
spleen  in  appreciable  numbers.  Nevertheless,  the  findings  reported  here  support 
previous conclusions that the ontogenetic development of predominant or "germ line" 
antibody specificities might be no different than the vast majority of nondominant 
clonotypes (26). Finally, it is interesting to note that monoclonal antibodies designated 
as CRIA  +  -- were identified in 6-d-old A/J spleens. Some of these idiotypic specificities 
may be generated as somatic variants from the germ line VH gene pool responsible for 
the  CRIA+  idiotype family. If this  is  the  case,  the  results would  also  suggest  that 
antibody diversification occurs at the stem cell stage and in the absence of antigenic 
contact.  Because the Vn  genes coding the  CRIA  have been cloned and  sequenced 
(29), mapping the ontogeny of certain private idiotypes known to be present only on 
variants of the germ line genetic information might provide a  more precise under- 
standing of the mechanisms of clonotype diversification. 
Summary 
A large proportion ofp-azophenylarsonate (ARS)-specific antibodies from A/J mice 
share a cross-reactive idiotype (CRIA) that comprises a  family of closely related but 
nonidentical clonotypes. I determined that only 2.6%  (7 out of 267) A/J ARS-specific 
monoclonal antibodies generated in the splenic focus system possess the predominant 
CRIA. Because ARS-specific B cells are present at a frequency of 1/68,000 B cells, the 
frequency of the entire idiotype family is  1 per 2.8 ×  106 splenic B cells. Thus, there 
is  a  striking  discrepancy between  the  representation  of this  idiotype at  the  clonal 
precursor cell level and the serum antibody response. In addition, BALB/c mice have 
the  potential  to  generate  CRIA-positive  precursor  cells  within  their  nonimmune 
repertoire. When A/J mice are immunized with ARS-protein conjugates, the serum 
antibody response and precursor cell population are both dominated by CRIA. The 
frequency ofCRIA-positive B cells increases over 100-fold after immunization, whereas 
CRIA-negative  precursor  cells  may  initially  decrease,  followed  by  a  later  rise  in 
frequency. Finally, although ARS-specific precursor cells are present in high frequency 
at birth, CRIA-positive monoclonal anti-ARS antibodies are not observed during the 
early neonatal period. These data provide evidence to suggest that complex regulatory 
networks influence precursor cell and serum antibody expression. 
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